| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |